Dengfeng Zou

Prof. Dengfeng Zou


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2019 in Materials Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
JSJian Shen
Jian Shen
JCJianjiao Chen
Jianjiao Chen
ZKZhen Ke
Zhen Ke
DZDengfeng Zou
Dengfeng Zou
LSLiguo Sun
Liguo Sun
JZJianhua Zou
Jianhua Zou
Photodynamic and photothermal synergistic therapy are newly developed approaches for cancer treatment. The design and preparation of photosensitizers of high phototoxicity as well as low dark toxicity are of increasing significance in minimizing the side effects and maximizing the phototherapy efficacy of such treatments. In this study, a heavy atom-free copolymer NDNT was designed and synthesized by the Stille coupling reaction. This compound shows a high singlet oxygen quantum yield of 55.2%, guaranteeing an excellent phototherapy efficacy. The nanoparticles (NPs) of NDNT obtained by nanoprecipitation with DSPE-PEG-2000 with an average diameter of 65 nm exhibit considerably high phototoxicity towards human prostate cancer cells (Du145) because their half inhibitory concentration (IC50) is as low as 3.8 μg mL−1. Simultaneously, the dark toxicity of the NPs is almost negligible, even at a high concentration. Furthermore, an in vivo study with laser irradiation by photodynamic and photothermal synergistic therapy demonstrates that the NPs are capable of inhibiting a Du145 tumor growth, compared with the control and dark group, suggesting the low dark toxicity and high phototoxicity of such NPs. The H&E stained pictures of the normal tissues show that no obvious damage occurred, indicating the biosafety of the NDNT NPs. These results provide a strategy for designing heavy atom-free copolymers for phototherapy both in vitro and in vivo.

28 February 2020 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
ZKZhen Ke
Zhen Ke
AXAize Xie
Aize Xie
JCJianjiao Chen
Jianjiao Chen
ZZZhenyuan Zou
Zhenyuan Zou
LSLei Shen
Lei Shen
DZDengfeng Zou
Dengfeng Zou
Naturally available compounds with bioactivity are potential candidates for cancer treatment. In this paper, we isolated hypericin (HC) from Hypericum sinense L. and investigated its antitumor activity both in vitro and in vivo. The nanoparticles (NPs) of HC were prepared by a nanoprecipitation process with 1,2-distearoyl-sn-glycero-3-phospho-ethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-PEG-2000). With light irradiation, HC NPs not only undergo efficient electron transfer to generate the superoxide radical (O2 −˙) and the hydroxyl radical (OH˙) as well as energy transfer producing singlet oxygen (1O2) for photodynamic therapy (PDT), but also non-radiative decay to produce heat for photothermal therapy (PTT) with a photothermal conversion efficiency of 29.3%. This synergistic therapy, therefore, largely boosts the phototherapy efficacy of HC NPs on human cervical cancer cells (HeLa), guaranteeing a low half maximal inhibitory concentration (IC50) of only 5.6 μg mL−1. Furthermore, in vivo studies suggest that HC NPs are capable of inhibiting tumor proliferation after laser irradiation, and the main organs remain healthy, including the heart, kidneys, liver, lungs and spleen. Our results indicate that HC NPs derived from nature with excellent phototherapy efficacies are biocompatible candidates for type I PDT/PTT synergistic cancer therapy.

1 September 2020 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
JYJie Yang
Jie Yang
XHXin He
Xin He
ZKZhen Ke
Zhen Ke
JCJianjiao Chen
Jianjiao Chen
ZZZhenyuan Zou
Zhenyuan Zou
JZJianhua Zou
Jianhua Zou

1 November 2020 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
HXHongliang Xu
Hongliang Xu
XZXujing Zhang
Xujing Zhang
XLXinchen Li
Xinchen Li
XZXiaochuan Zhang
Xiaochuan Zhang
JDJun Deng
Jun Deng
JYJie Yang
Jie Yang

1 November 2020 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
XZXujing Zhang
Xujing Zhang
XHXiao Huang
Xiao Huang
AXAize Xie
Aize Xie
XZXiaochuan Zhang
Xiaochuan Zhang
JDJun Deng
Jun Deng
JZJianhua Zou
Jianhua Zou

1 February 2021 in Materials Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
DZDengfeng Zou
Dengfeng Zou
AZAolin Zhang
Aolin Zhang
JCJianjiao Chen
Jianjiao Chen
ZCZhiqiang Chen
Zhiqiang Chen
JDJun Deng
Jun Deng
JYJie Yang
Jie Yang
Developing intelligent photosensitizers (PSs) responding to the tumor microenvironment (TME) to maximize the therapeutic efficacy and minimize side effects is a major problem for tumor phototherapy. In this paper, a dimethylamino (–NMe2)-functionalized boron dipyrromethene (Bodipy) derivative, namely, (E)-3-(4-(dimethylamino)styryl)-5,5-difluoro-2,8-diiodo-1,7,9-trimethyl-10-phenyl-5H-di-pyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinin-4-ium-5-uide (BDPIN) has been designed and synthesized by a Knoevenagel condensation reaction. BDPIN has a high singlet oxygen quantum yield (1O2 QY) of 74.8% in dichloromethane, and retains high 1O2 generation ability when nanoprecipitated in water with DSPE-PEG. For the synergistic therapy (photothermal conversion efficiency ∼28.6%), BDPIN NPs show a low half maximum inhibitory concentration (IC50) of 4.4 μg mL−1 towards human cervical cancer cells (HeLa). However, the dark toxicity of BDPIN NPs is almost negligible even at high concentrations. NPs with lysosome targeting ability can be triggered by the low acidity for enhanced phototherapy. Furthermore, an in vivo study demonstrates that NPs are able to inhibit tumor proliferation with laser irradiation, while causing no damage to normal tissues, suggesting the high phototoxicity, low dark toxicity and outstanding biosafety of BDPIN NPs. Results provide an approach for synthesizing nanomedicine in pH-activated enhanced phototheranostics.